Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV (TiP)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by Centers for Disease Control and Prevention.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
National Center for AIDS/STD Control and Prevention, China CDC
Information provided by (Responsible Party):
Athena Kourtis, Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT01125696
First received: March 29, 2010
Last updated: February 2, 2015
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)